Skip to main content
SpringerLink
Log in

Experimentelle Behandlungsansätze und Zukunftsperspektiven bei therapieresistenten Depressionen

  • Conference paper
Therapieresistente Depressionen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amsterdam JD (1991) Use of high dose tranylcypromine in resistant depression. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology. Volume 2: Refractory depression. Raven Press, New York, pp 123 - 129

    Google Scholar 

  • Amsterdam JD, Berwish W (1987) Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy. J Clin Psychopharmacol 7: 238 - 242

    Article  PubMed  CAS  Google Scholar 

  • Amsterdam JD, Rosenzweig M, Mozley PD (1994) Assessment of adrenocortical activity in refractory depression: Steroid suppression with ketokonazole. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons

    Google Scholar 

  • Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, Rames LJ, Roberts JM, Dias JK, Molloy M (1995) Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-blind trial. Am J Psychiat 152: 265-267

    Google Scholar 

  • Artigas F (1995) Pindolol, 5-hydroxytryptamine, and antidepessant augmentation. Arch Gen Psychiat 52: 969-971

    Google Scholar 

  • Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiat 51: 248 - 251

    Article  PubMed  CAS  Google Scholar 

  • Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15: 243-245

    Google Scholar 

  • Benkert O, Hippius H (1992) Psychiatrische Pharmakotherapie. 5., vollst. überarbeitete Auflage. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  • Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217 - 222

    Article  PubMed  CAS  Google Scholar 

  • Davidson C, Starnford JA (1995) Pindolol potentiates the effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus. Neuropsychopharmacol 5: 278 (Abstract)

    Google Scholar 

  • Dinan T (1994) Glucocorticoids and the genesis of depressive illness: A psychobiological model. Br J Psychiat 164: 365 - 371

    Article  CAS  Google Scholar 

  • Folks DG, King LD, Dowdy SB, Petrie WM, Jack RA, Koomen JC, Swenson BR, Edwards P (1982) Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiat 139: 115 - 117

    PubMed  CAS  Google Scholar 

  • Haskovec L, Rysanek K (1967) The action of reserpine in imipramine-resistant depressive patients. Psychopharmacol n: 18 - 30

    Google Scholar 

  • Heinz A, Schmidt LG, Reischies F (1994) Anhedonia in depressed, schizophrenic and alcohol-dependent patients - neurobiological correlates. Psychopharmacol 27 (suppl.): 7 - 10

    Google Scholar 

  • Holsboer F, Benkert O, Demisch L (1983) Changes in MAO activity with endogenous depression. Mod Probl Pharmacopsychiatry 19: 321 - 326

    PubMed  CAS  Google Scholar 

  • Howland RH, Kupfer DJ (1993) Refractory depression. New directions. Clin Neurosc 1: 81-85

    Google Scholar 

  • Ketter TA, Pazzaglia PJ, Post RM (1992) Synergy of carbamazepine and valproic acid in affective illness: case report and review of literature. J Clin Psychopharmacol 12: 276 - 281

    Article  PubMed  CAS  Google Scholar 

  • Ketter TA, Post RM, Parekh PI, Worthington K (1995) Addition of monoamine oxidase inhibitors to carbamazepine: Preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. J Clin Psychiatry 56: 471-475

    Google Scholar 

  • Kindler S, Lustig M, Kotler M, Sasson Y, Zohar J (1994a) The role of psychostimulants in the treatment of depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons, Chichester, pp 147 - 154

    Google Scholar 

  • Kindler S, Sasson Y, Cohen R, Zohar J (1994c) The role of oestrogen augmentation in females with refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons, Chichester, pp 155 - 158

    Google Scholar 

  • Kindler S, Sasson Y, Dolberg O, Zohar J (1994b) The role of reserpine augmentation in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons, Chichester, pp 159 - 162

    Google Scholar 

  • Klaiber EL, Broverman DM, Vogel W, Kobayashi T (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiat 36: 550 - 554

    Article  PubMed  CAS  Google Scholar 

  • McGrath PJ, Stewart JW, Harrison W, Quitkin FM (1987) Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. Psychopharmacol Bull 23: 169 - 172

    PubMed  CAS  Google Scholar 

  • Meltzer HY, Maes M, Elkis H (1994) The biological basis of refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons, Chichester, pp 177 - 198

    Google Scholar 

  • Nolen WA, Bouvy PF, Haffmans PMJ, Duivenvoorden HJ (1993) Monoamine oxidase inhibitors in resistant depression: a double-blind comparison of brofaromine and tranylcypromine in patients resistant to (tri)cyclic antidepressants. J Affect Disord 28: 189 - 197

    Article  PubMed  CAS  Google Scholar 

  • Nolen WA, Hoencamp E, Haffmans PMJ, Bouvy PF (1994) Classical and selective monoamineoxidase inhibitors in refractory major depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions. John Wiley und Sons, Chichester, pp 59 - 68

    Google Scholar 

  • Nolen WA, Van de Putte JJ, Dijken WA (1988) Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled studies with tranylcypromine versus 1-5-hydroxytryptophan and nomifensine. Acta Psychiat Scand 78: 676 - 683

    Article  PubMed  CAS  Google Scholar 

  • Oppenheim G (1984) A case of rapid mood cycling with estrogen: Implications for therapy. J Clin Psychiat 45: 34-35

    Google Scholar 

  • Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, Marangell L, George MS (1994) Anticonvulsants in refractory mood disorder. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: current strategies and future directions. John Wiley und Sons, Chichester, pp 97 - 114

    Google Scholar 

  • Post RM, Rubinow DR, Ballenger JC (1986a) Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiat 149: 191 - 201

    Article  CAS  Google Scholar 

  • Post RM, Uhde TW, Roy-Byrne PP, Joffe RT (1986b) Antidepressant effects of carbamazepine. Am J Psychiat 143: 29 - 34

    PubMed  CAS  Google Scholar 

  • Potter WZ, Manji HK (1994) Dopaminergic drugs and systems in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: current strategies and future directions. John Wiley und Sons, Chichester, pp 211 - 227

    Google Scholar 

  • Prange AJ jr, Wilson IC, Breese GR, Lipton MA (1976) Hormonal alteration of imipramine response: A review. In: Sachar EJ (ed) Hormones, behavior, and psychopathology. Raven Press, New York

    Google Scholar 

  • Sachar EJ, Kanter SS, Buie D, Engle R, Mehlman R (1970) Psychoendocrinology of ego disintegration. Am J Psychiat 123: 387 - 400

    Google Scholar 

  • Satel SL, Nelson C (1989) Stimulants in the treatment of depression: A critical overview. J Clin Psychiat 50: 241-249

    Google Scholar 

  • Sharma V, Persad E, Kueneman K, Mazmanian D, Wadden P (1994) Lithium augmentation of valproic acid in treatment resistant depression. Lithium 5: 99-103

    Google Scholar 

  • Sherwin BB (1991) Estrogen and refractory depression. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology. Volume 2: Refractory depression. Raven Press, New York, pp 209 - 218

    Google Scholar 

  • Small JG (1990) Anticonvulsants in affective disorders. Psychopharmacol Bull 26: 25 - 36

    PubMed  CAS  Google Scholar 

  • Sulser F (1987) Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders. J Clin Psychiat 48: 12 - 18

    CAS  Google Scholar 

  • Sulser F (1991) The neurochemistry of refractory depression. A molecular view on therapy-resistant signal transfer. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psycho-pharmacology. Volume 2: Refractory depression. Raven Press, New York, pp 13 - 21

    Google Scholar 

  • Watson NR, Studd JWW (1990) Gonadal hormones and depression in women. In: Cobb J, Goeting NLM (eds) Current approaches: Prediction and treatment of recurrent depression. Duphar Medical Relations

    Google Scholar 

  • Wharton RN, Perel JM, Dayton PG, Malitz S (1971) A potential clinic use for methylphenidate with TCAs. Am J Psychiat 127: 55 - 61

    Google Scholar 

  • Wise RA (1989) Brain dopamine and reward. Ann Rev Psychol 40: 191 - 225

    Article  CAS  Google Scholar 

  • Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H (1993) Ketokonazole administration in hypercortisolemic depression. Am J Psychiat 150: 810 - 812

    PubMed  CAS  Google Scholar 

  • Wunderlich HP, Grunes JU, Buchsbaum MS (1983) Antidepressive therapy with carbamazepine (Finlepsin). Schweiz Arch Neurol Neurochir Psychiatr 133: 363-371

    Google Scholar 

  • Zohar J, Kaplan Z, Amsterdam JD (1991) Reserpine augmentation in resistant depression: A review. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology. Volume 2: Refractory depression. Raven Press, New York, pp 219 - 222

    Google Scholar 

Download references

Authors
  1. A. Heinz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Freien Universität Berlin, Eschenallee 3, 14050, Berlin, Deutschland

    Michael Bauer  & Anne Berghöfer (Ärztin) &  (Ärztin)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heinz, A. (1997). Experimentelle Behandlungsansätze und Zukunftsperspektiven bei therapieresistenten Depressionen. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10500-9_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61675-7

  • Online ISBN: 978-3-662-10500-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation